147 related articles for article (PubMed ID: 36683525)
1. A novel variant in BCL11B in an individual with neurodevelopmental delay: A case report.
Yu Y; Jia X; Yin H; Jiang H; Du Y; Yang F; Yang Z; Li H
Mol Genet Genomic Med; 2023 Apr; 11(4):e2132. PubMed ID: 36683525
[TBL] [Abstract][Full Text] [Related]
2. A De Novo heterozygous frameshift mutation identified in BCL11B causes neurodevelopmental disorder by whole exome sequencing.
Qiao F; Wang C; Luo C; Wang Y; Shao B; Tan J; Hu P; Xu Z
Mol Genet Genomic Med; 2019 Sep; 7(9):e897. PubMed ID: 31347296
[TBL] [Abstract][Full Text] [Related]
3. BCL11B-related disorder in two canadian children: Expanding the clinical phenotype.
Prasad M; Balci TB; Prasad C; Andrews JD; Lee R; Jurkiewicz MT; Napier MP; Colaiacovo S; Guillen Sacoto MJ; Karp N
Eur J Med Genet; 2020 Sep; 63(9):104007. PubMed ID: 32659295
[TBL] [Abstract][Full Text] [Related]
4. BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells.
Lessel D; Gehbauer C; Bramswig NC; Schluth-Bolard C; Venkataramanappa S; van Gassen KLI; Hempel M; Haack TB; Baresic A; Genetti CA; Funari MFA; Lessel I; Kuhlmann L; Simon R; Liu P; Denecke J; Kuechler A; de Kruijff I; Shoukier M; Lek M; Mullen T; Lüdecke HJ; Lerario AM; Kobbe R; Krieger T; Demeer B; Lebrun M; Keren B; Nava C; Buratti J; Afenjar A; Shinawi M; Guillen Sacoto MJ; Gauthier J; Hamdan FF; Laberge AM; Campeau PM; Louie RJ; Cathey SS; Prinz I; Jorge AAL; Terhal PA; Lenhard B; Wieczorek D; Strom TM; Agrawal PB; Britsch S; Tolosa E; Kubisch C
Brain; 2018 Aug; 141(8):2299-2311. PubMed ID: 29985992
[TBL] [Abstract][Full Text] [Related]
5. Identification of two novel variants of the
Che F; Tie X; Lei H; Zhang X; Duan M; Zhang L; Yang Y
Front Mol Neurosci; 2022; 15():927357. PubMed ID: 36176959
[TBL] [Abstract][Full Text] [Related]
6. Mutant
Yang S; Kang Q; Hou Y; Wang L; Li L; Liu S; Liao H; Cao Z; Yang L; Xiao Z
Front Pediatr; 2020; 8():544894. PubMed ID: 33194885
[No Abstract] [Full Text] [Related]
7. [A case report of BCL11B mutation induced neurodevelopmental disorder and literature review].
Yan S; Wei YS; Yang QY; Yang L; Zeng T; Tang XM; Zhao XD; An YF
Zhonghua Er Ke Za Zhi; 2020 Mar; 58(3):223-227. PubMed ID: 32135595
[No Abstract] [Full Text] [Related]
8. Further validation of craniosynostosis as a part of phenotypic spectrum of BCL11B-related BAFopathy.
Pande S; Mascarenhas S; Venkatraman A; Bhat V; Narayanan DL; Siddiqui S; Bielas S; Girisha KM; Shukla A
Am J Med Genet A; 2023 Aug; 191(8):2175-2180. PubMed ID: 37337996
[TBL] [Abstract][Full Text] [Related]
9. Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B.
Punwani D; Zhang Y; Yu J; Cowan MJ; Rana S; Kwan A; Adhikari AN; Lizama CO; Mendelsohn BA; Fahl SP; Chellappan A; Srinivasan R; Brenner SE; Wiest DL; Puck JM
N Engl J Med; 2016 Dec; 375(22):2165-2176. PubMed ID: 27959755
[TBL] [Abstract][Full Text] [Related]
10. Depletion of B cell CLL/Lymphoma 11B Gene Expression Represses Glioma Cell Growth.
Liao CK; Fang KM; Chai K; Wu CH; Ho CH; Yang CS; Tzeng SF
Mol Neurobiol; 2016 Aug; 53(6):3528-3539. PubMed ID: 26096706
[TBL] [Abstract][Full Text] [Related]
11. Clinico-biological refinement of BCL11B-related disorder and identification of an episignature: A series of 20 unreported individuals.
Sabbagh Q; Haghshenas S; Piard J; Trouvé C; Amiel J; Attié-Bitach T; Balci T; Barat-Houari M; Belonis A; Boute O; Brightman DS; Bruel AL; Caraffi SG; Chatron N; Collet C; Dufour W; Edery P; Fong CT; Fusco C; Gatinois V; Gouy E; Guerrot AM; Heide S; Joshi A; Karp N; Keren B; Lesieur-Sebellin M; Levy J; Levy MA; Lozano C; Lyonnet S; Margot H; Marzin P; McConkey H; Michaud V; Nicolas G; Nizard M; Paulet A; Peluso F; Pernin V; Perrin L; Philippe C; Prasad C; Prasad M; Relator R; Rio M; Rondeau S; Ruault V; Ruiz-Pallares N; Sanchez E; Shears D; Siu VM; Sorlin A; Tedder M; Tharreau M; Mau-Them FT; van der Laan L; Van Gils J; Verloes A; Whalen S; Willems M; Yauy K; Zuntini R; Kerkhof J; Sadikovic B; Geneviève D
Genet Med; 2024 Jan; 26(1):101007. PubMed ID: 37860968
[TBL] [Abstract][Full Text] [Related]
12. A Novel Germline Heterozygous
Lu HY; Sertori R; Contreras AV; Hamer M; Messing M; Del Bel KL; Lopez-Rangel E; Chan ES; Rehmus W; Milner JD; McNagny KM; Lehman A; Wiest DL; Turvey SE
Front Immunol; 2021; 12():788278. PubMed ID: 34887873
[TBL] [Abstract][Full Text] [Related]
13. Novel BCL11B truncation variant in a patient with developmental delay, distinctive features, and early craniosynostosis.
Eto K; Machida O; Yanagishita T; Shimojima Yamamoto K; Chiba K; Aihara Y; Hasegawa Y; Nagata M; Ishihara Y; Miyashita Y; Asano Y; Nagata S; Yamamoto T
Hum Genome Var; 2022 Dec; 9(1):43. PubMed ID: 36470856
[TBL] [Abstract][Full Text] [Related]
14. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
[TBL] [Abstract][Full Text] [Related]
15. Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients.
Bartram I; Gökbuget N; Schlee C; Heesch S; Fransecky L; Schwartz S; Stuhlmann R; Schäfer-Eckhart K; Starck M; Reichle A; Hoelzer D; Baldus CD; Neumann M
J Hematol Oncol; 2014 Jul; 7():51. PubMed ID: 25023966
[TBL] [Abstract][Full Text] [Related]
16. Molecular Diagnostic Yield of Exome Sequencing in Patients With Cerebral Palsy.
Moreno-De-Luca A; Millan F; Pesacreta DR; Elloumi HZ; Oetjens MT; Teigen C; Wain KE; Scuffins J; Myers SM; Torene RI; Gainullin VG; Arvai K; Kirchner HL; Ledbetter DH; Retterer K; Martin CL
JAMA; 2021 Feb; 325(5):467-475. PubMed ID: 33528536
[TBL] [Abstract][Full Text] [Related]
17. Case report: A novel truncating variant of
Zhao X; Wu B; Chen H; Zhang P; Qian Y; Peng X; Dong X; Wang Y; Li G; Dong C; Wang H
Front Pediatr; 2022; 10():982361. PubMed ID: 36275064
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of BCL11B and its recruited chromatin remodeling factors during highly active antiretroviral therapy synergistically represses the transcription of human immunodeficiency virus type 1 and is associated with residual immune activation.
Wang J; Yang Z; Wu NP; Yang J
Arch Virol; 2020 Feb; 165(2):321-330. PubMed ID: 31828511
[TBL] [Abstract][Full Text] [Related]
19. Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia.
Liang T; Wang X; Liu Y; Ai H; Wang Q; Wang X; Wei X; Song Y; Yin Q
Front Immunol; 2022; 13():985280. PubMed ID: 36211334
[TBL] [Abstract][Full Text] [Related]
20. A Bcl11b
Matsumoto K; Okuyama K; Sidwell T; Yamashita M; Endo T; Satoh-Takayama N; Ohno H; Morio T; Rothenberg EV; Taniuchi I
Front Immunol; 2024; 15():1363704. PubMed ID: 38495886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
